Your Article Summary
See Latest ArticlesInvestigation of a new 1,3-diarylpropenone as a potential antimitotic agent targeting bladder carcinoma
Anti-Cancer Drugs, 07/01/09
Martel-Frachet V et al. - After treating the cells with IPP51 for 24 h, the title compound induced a predominant and reversible G2+M accumulation at the prometaphase stage of mitosis. However, when used for a longer period, it leads to cell apoptosis. These results suggest that the compound has potential anticancer activities, which could be useful in bladder cancer treatment.
Related Articles
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer, 11/13/09
Relevance Score: 70%
Evidence-based Principles of Bladder Cancer and Diet
Urology, 10/21/09
Relevance Score: 70%
Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09
Relevance Score: 70%
Biomarkers in bladder cancer
BJU International, 10/01/09
Relevance Score: 70%
Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09
Relevance Score: 70%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder
BJU International, 12/02/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
High-grade prostate cancer and finasteride
BJU International, 12/02/09
Reboxetine in therapy-resistant enuresis: A retrospective evaluation
Scandinavian Journal of Urology and Nephrology, 12/01/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells
BMC Cancer, 12/02/09
Testicular Metastasis of Prostatic Cancer
Urology, 12/02/09